Participants 55 101 4
patients with gallstones: a multicenter trial.
Participants 103 240 6
24 gallstone patients were treated with cicloxilic acid, an agent endowed with choleretic activity, at the dose of 240 mg/day for 1 month
Participants 242 303 3
24 comparable patients on placebo treatment acted as controls
